David L. Porter, MD, University of Pennsylvania

Articles by David L. Porter, MD, University of Pennsylvania

How New and Emerging Trends in CAR T-Cell Therapy Can Affect Your Patients

ByDavid L. Porter, MD, University of Pennsylvania,Jason Westin, MD, MS, FACP, MD Anderson Cancer Center,Elizabeth Budde, MD, PhD

October 16th 2020

Latest Updated Articles

How New and Emerging Trends in CAR T-Cell Therapy Can Affect Your Patients
October 16th 2020

Trending on OncLive

FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL

Oral Azacitidine and Cedazuridine Meets Primary Pharmacokinetic End Point in MDS and CMML

Revisit Every OncLive On Air Episode From September 2026

UTRxMYCN M1-14 Nets FDA Dual Designations in Soft Tissue Sarcoma

Optune Pax Is Approved in Japan for Unresectable Locally Advanced Pancreatic Cancer